BioCryst Pharmaceuticals BCRX Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount
Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount at other companies
Other financials
Where this comes from
Reported directly by BioCryst Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance.
The official record: BioCryst Pharmaceuticals’s 10-K, filed February 26, 2026, on SEC EDGAR. View the filing →
Ask your AI about BioCryst Pharmaceuticals's effective income tax rate reconciliation, change in deferred tax assets valuation allowance, amount.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is BioCryst Pharmaceuticals's effective income tax rate reconciliation, change in deferred tax assets valuation allowance, amount?
- BioCryst Pharmaceuticals (BCRX) reported effective income tax rate reconciliation, change in deferred tax assets valuation allowance, amount of -$13.11M in Q4 2025.
- How has BioCryst Pharmaceuticals's effective income tax rate reconciliation, change in deferred tax assets valuation allowance, amount changed year-over-year?
- BioCryst Pharmaceuticals's effective income tax rate reconciliation, change in deferred tax assets valuation allowance, amount decreased by 703.3% year-over-year, from $2.17M to -$13.11M.
- What is the long-term trend for BioCryst Pharmaceuticals's effective income tax rate reconciliation, change in deferred tax assets valuation allowance, amount?
- Over 4 years (2021 to 2025), BioCryst Pharmaceuticals's effective income tax rate reconciliation, change in deferred tax assets valuation allowance, amount has grown at a 2.3% compound annual growth rate (CAGR), from $47.95M to -$52.45M.
- What does effective income tax rate reconciliation, change in deferred tax assets valuation allowance, amount mean?
- Measures the absolute change in the valuation allowance established against deferred tax assets. A significant change reflects management's assessment of the probability that the company will generate sufficient future taxable income to realize these assets. This is a key indicator of the company's long-term profitability outlook and tax planning strategy.